QUICK BIOLOGY INC

Quick Biology Inc. specializes in the manufacturing of biological products and the operation of advanced testing laboratories, with a focused expertise in RNA sequencing for biomedical research. The company delivers high-precision molecular analysis services, particularly in the study of aging and cellular senescence, utilizing next-generation sequencing platforms to generate transcriptomic data critical for understanding biological aging pathways. Their technical capabilities include sample preparation, library construction, high-throughput sequencing, and bioinformatic analysis of RNA datasets, supporting research initiatives in regenerative medicine and age-related disease mechanisms. The firm’s ability to integrate manufacturing of biological reagents with analytical laboratory services enables end-to-end workflow solutions for complex research programs. Quick Biology Inc. has established a consistent relationship with the Department of Health and Human Services, providing mission-critical laboratory and manufacturing support for federally funded aging and senescence research. Their work with HHS centers on delivering validated biological materials and sequencing services that meet rigorous scientific and regulatory standards for preclinical research, indicating a strong alignment with NIH and other HHS component agency priorities. The contractor operates primarily within the biological product manufacturing (NAICS 325414) and testing laboratories (NAICS 541380) sectors, positioning itself at the intersection of biomanufacturing and molecular diagnostics research. This dual focus allows them to support both the production of research-grade biological materials and the analytical validation of their function, serving niche markets in academic and government-funded biomedical science. While specific certifications and organizational structure are not disclosed, Quick Biology Inc. demonstrates a targeted presence in the federal biomedical research market, delivering specialized services that require strict adherence to biosafety, quality control, and data integrity protocols. Their geographic footprint and business size remain undisclosed, but their contract history reflects a lean, technically agile operation focused on high-value, research-driven government projects.